2024
Management of the refractory nocturnal enuresis patient to desmopressin in a pediatric population: Desmopressin + oxybutynin vs. desmopressin + imipramine
Shain S, Gitlin J, Pantazis A, Fine R, Horowitz M, Friedman S, Zelkovic P, Dyer L, Schlussel R, Freyle J, Fang A, Sommer J, Franco I. Management of the refractory nocturnal enuresis patient to desmopressin in a pediatric population: Desmopressin + oxybutynin vs. desmopressin + imipramine. Journal Of Pediatric Urology 2024, 20: 603.e1-603.e8. PMID: 38871547, DOI: 10.1016/j.jpurol.2024.05.024.Peer-Reviewed Original ResearchVancouver Symptom ScoreInternational Children's Continence SocietyWet nightsDesmopressin treatmentCombination therapyResponse rateIntent-to-treat response rateCombination therapy of desmopressinFirst-line medical therapyEfficacy of adjunctive therapyGroup IMPComplete response rateTreated with desmopressinCohort of patientsContinence successPrescribed desmopressinEnuresis patientsMedical therapyNighttime drynessChart reviewAdjunctive therapyConclusion A combinationDesmopressinOxybutyninPediatric population
2009
Pediatric Urolithiasis: Medical Treatment and Outcomes
Wong J, Weiss R, Friedman S, Pagala M, Franco I. Pediatric Urolithiasis: Medical Treatment and Outcomes. Journal Of Pediatric Urology 2009, 5: s34. DOI: 10.1016/j.jpurol.2009.02.039.Peer-Reviewed Original ResearchPotassium citrateFull metabolic evaluationPotassium citrate groupsMainstay of treatmentResultsThe mean ageUntreated controlsMethodsBetween 2002Standard therapyRetrospective studyMean ageCombination therapyMetabolic evaluationUrine testsUrolithiasis patientsPatientsExcretion rateThiazidesTherapySignificant riskCitrate groupUric acidT-testCalcium oxalateSignificant improvementHypocitraturia